10-QPeriod: Q1 FY2012

QUEST DIAGNOSTICS INC Quarterly Report for Q1 Ended Mar 31, 2012

Filed April 27, 2012For Securities:DGX

Summary

Quest Diagnostics Inc. (DGX) reported a significant turnaround in its financial performance for the first quarter of 2012, moving from a net loss in the prior year to a substantial net income. Net revenues increased by 6.3% year-over-year, driven by organic volume growth in clinical testing and contributions from recent acquisitions. The company also demonstrated strong operational efficiency, with total operating costs and expenses decreasing by 13.8% due to the absence of a large legal settlement charge from the prior year and ongoing cost-saving initiatives. Key financial highlights include a robust increase in income from continuing operations, turning a significant loss into a profit, and a substantial improvement in diluted earnings per share. The company also maintained healthy operating cash flow. Management's focus on cost reduction and operational efficiency, coupled with strategic acquisitions, positions Quest Diagnostics for continued profitability. Investors should note the ongoing implementation of cost-saving programs and potential charges associated with them, as well as continued strategic acquisitions as key drivers for future performance.

Financial Highlights

56 data points
Beta

Revenue

$1.91B

41.9% Gross Margin

Net Income

$159.00M

8.3% Net Margin

EPS (Diluted)

$0.99

Total Assets

$9.45B

Cash & Equivalents

$145.44M

Free Cash Flow

$131.27M

Financial Statements
Beta
Revenue$1.91B
Cost of Revenue$1.11B
Gross Profit$800.00M
SG&A Expenses$483.25M
Operating Expenses$1.61B
Operating Income$297.82M
Interest Expense$42.99M
Net Income$159.00M
EPS (Basic)$1.00
EPS (Diluted)$0.99
Shares Outstanding (Basic)158.29M
Shares Outstanding (Diluted)159.71M

Key Highlights

  • 1Net revenues increased by 6.3% to $1.94 billion in Q1 2012 compared to $1.82 billion in Q1 2011, driven by organic growth and acquisitions.
  • 2The company reported a net income of $168.5 million in Q1 2012, a significant improvement from a net loss of $46.7 million in Q1 2011.
  • 3Diluted earnings per share (EPS) improved dramatically to $0.99 in Q1 2012 from a loss of ($0.33) in Q1 2011.
  • 4Operating income saw a substantial increase, rising to $299.6 million in Q1 2012 from $31.0 million in Q1 2011, with operating margin improving significantly.
  • 5Cash flow from operating activities remained strong at $161.3 million in Q1 2012, consistent with the prior year.
  • 6The company is actively executing a multi-year cost reduction program aimed at saving $500 million by the end of 2014, with estimated pre-tax charges of $100-$175 million.
  • 7Quest Diagnostics completed the acquisition of S.E.D. Medical Laboratories in January 2012 for approximately $50.5 million, further bolstering its strategic position.

Frequently Asked Questions

The substantial increase in net income was primarily driven by the absence of a large $236 million Medi-Cal charge recorded in Q1 2011. Additionally, revenue growth from recent acquisitions (Athena, Celera, S.E.D.) and improved operating efficiency contributed to the positive turnaround.

The company has committed to a multi-year program to reduce its cost structure by $500 million by the end of 2014. This initiative focuses on standardizing processes, increasing automation, centralizing activities, and selective outsourcing across client support, laboratory operations, and administrative functions. Estimated pre-tax charges for this program range from $100 million to $175 million.

Recent acquisitions, including Athena Diagnostics, Celera Corporation, and S.E.D. Medical Laboratories, have contributed to revenue growth, particularly in the clinical testing segment. The Athena and Celera acquisitions, in particular, have benefited revenue per requisition through an increased mix of gene-based and esoteric testing.

Quest Diagnostics has a balanced mix of fixed and variable-rate debt. The company utilizes interest rate swaps to manage interest rate risk. As of March 31, 2012, the company had approximately $1.0 billion in borrowing capacity available under its credit facilities. Management believes its cash on hand, operating cash flow, and available credit lines are sufficient to meet its financial obligations and fund future growth.